Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Nurgul Ozgur Yurttas, MD, Burak Sarilar, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Ayse Salihoglu, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2017) 130 (Supplement 1): 2888.

https://doi.org/10.1182/blood.V130.Suppl_1.2888.2888

Published: 2017

Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5213.

https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213

Published: 2017

Journal Articles

Genomic Applications for Transfusion Support

Stella Chou, MD

Blood (2016) 128 (22): SCI-23.

https://doi.org/10.1182/blood.V128.22.SCI-23.SCI-23

Published: 2016

Journal Articles

A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization

Romulo Celli, MD, Wade L Schulz, MD PhD, Jeanne E. Hendrickson, MD, Christopher A Tormey, MD

Blood (2015) 126 (23): 2349.

https://doi.org/10.1182/blood.V126.23.2349.2349

Published: 2015

Journal Articles

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Pinar Ataca, MD, Erden Atilla, MD, Ekin Kircali, MD, Ramazan Idilman, MD, Meral Beksac, MD

Blood (2015) 126 (23): 5377.

https://doi.org/10.1182/blood.V126.23.5377.5377

Published: 2015

Journal Articles

Antiviral Efficacy Analysis of Telbivudine Concurrent with the First Cycle of Chemotherapy in HBsAg-Positive Lymphoma Patients

Wenyu Li, Doctor of MDcine, Ling Huang, Master of MDcine, Hanguo Guo, undergraduate, Xiaojuan Wei, undergraduate, Zhanli Liang, undergraduate

Blood (2014) 124 (21): 4437.

https://doi.org/10.1182/blood.V124.21.4437.4437

Published: 2014

Journal Articles

Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study

Xiao-Hui Zhang, MD, PhD, Ru Feng, Lan-ping Xu, Qian Jiang, Hao Jiang, Hai-xia Fu, Hui Liu, Ting Niu, Xin Wang, Jian-da Hu, Ming Jiang, Zhao Wang, Jing-wen Wang, Hui Ma, Yan-di Xie, Xiao-lu Zhu, Hao Wang, Lai Wei, Xiao Jun Huang

Blood (2014) 124 (21): 2778.

https://doi.org/10.1182/blood.V124.21.2778.2778

Published: 2014

Journal Articles

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Qingqing Cai, MD PhD, Kailin Chen, MD, Qirong Geng, MD, Guangzheng Zhong, MD, Jianping Li, MD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Wenqi Jiang, MD PhD, Zhiming Li, MD PhD

Blood (2014) 124 (21): 1655.

https://doi.org/10.1182/blood.V124.21.1655.1655

Published: 2014

Journal Articles

Risk Factors of Changes in Hepatitis B Antibody Status after Allogeneic Hematopoietic Stem Cell Transplantation in Chinese Children with Thalassemia Major

Xiaoqin Feng, Lina Long, Chunfu Li, MD

Blood (2014) 124 (21): 5809.

https://doi.org/10.1182/blood.V124.21.5809.5809

Published: 2014

Journal Articles

Hepatitis B Related Serological Events In Hematopoietic Stem Cell Transplant Patients and Efficacy Of Lamivudine Prophylaxis Against Reactivation

Alok Gupta, MD, Bhausaheb Bagal, MD, DM., Jayant Gawande, MD, DM, Sachin Punatar, MD, Bharat Chauhan, MD, Libin Mathew, Vivek Bhat, MD, Sadhana Kannan, MSc, Navin Khattry, MD, DM.

Blood (2013) 122 (21): 2043.

https://doi.org/10.1182/blood.V122.21.2043.2043

Published: 2013

Journal Articles

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Malgorzata Sobczyk-Kruszelnicka, Miroslaw Markiewicz, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Agnieszka Wieclawek, Anna Soja, Monika Dzierzak-Mietla, MD, Anna Koclega, Krzysztof Bialas, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2012) 120 (21): 4494.

https://doi.org/10.1182/blood.V120.21.4494.4494

Published: 2012

Journal Articles

Variant RH in Patients with Sickle Cell Disease Is Associated with Clinically Significant Alloimmunization

Stella T Chou, MD, Tannoa Jackson, Sunitha Vege, David Friedman, MD, Connie M Westhoff, PhD

Blood (2012) 120 (21): 3239.

https://doi.org/10.1182/blood.V120.21.3239.3239

Published: 2012

Journal Articles

Hepatitis B and Hepatitis C Co-Infection in Patients with Hematological Malignancies

Tatyana Ts Garmaeva, Sergey M. Kulikov, Elena A Michailova, Andrei B Sudarikov, Felix P Filatov, Valeryi G Savchenko

Blood (2011) 118 (21): 2090.

https://doi.org/10.1182/blood.V118.21.2090.2090

Published: 2011

Journal Articles

Use of Genomics for Transfusion Therapy Management in Patients with Sickle Cell Disease

Connie M Westhoff, PhD, Stella T Chou, MD, Kim Smith-Whitley, MD, David Friedman, MD

Blood (2011) 118 (21): 2324.

https://doi.org/10.1182/blood.V118.21.2324.2324

Published: 2011

Journal Articles

Long-Term Monitoring of Patients with Hematological Malignancies and Hepatitis B and Hepatitis C Virus Infections

Tatyana Garmaeva, Sergei Kulikov, Elena Michailova, Andrey Sudarikov, Felix Filatov, Valeryi Savchenko

Blood (2008) 112 (11): 3976.

https://doi.org/10.1182/blood.V112.11.3976.3976

Published: 2008

Journal Articles

Fulminant B Hepatitis in a Hepatitis B Surface Antigen-Negative Patient after Rituximab Therapy for B-CLL.

Pasquale Niscola, Maria Ilaria Del Giudice, Luca Maurillo, Mariacarmela Solmone, Maria Rosaria Capobianchi, Fabrizio Carletti, Daniela Piccioni, Adriano Venditti, Sergio Amadori, Giovanni Del Poeta

Blood (2005) 106 (11): 5025.

https://doi.org/10.1182/blood.V106.11.5025.5025

Published: 2005

Journal Articles

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

Oren Shibolet, Yaron Ilan, Shmuel Gillis, Ayala Hubert, Daniel Shouval, Rifaat Safadi

Blood (2002) 100 (2): 391–396.

https://doi.org/10.1182/blood.V100.2.391

Published: 2002

Journal Articles

Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment

Riccardo Utili, Rosa Zampino, Pasquale Bellopede, Marta Marracino, Enrico Ragone, Luigi Elio Adinolfi, Giuseppe Ruggiero, Maria Capasso, Paolo Indolfi, Fiorina Casale, Adele Martini, Maria Teresa Di Tullio

Blood (1999) 94 (12): 4046–4052.

https://doi.org/10.1182/blood.V94.12.4046

Published: 1999

NARROW

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Genomic Applications for Transfusion Support

A Novel Network Analysis Tool to Identify Relationships Between Disease States and Risk for RBC Alloimmunization

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Antiviral Efficacy Analysis of Telbivudine Concurrent with the First Cycle of Chemotherapy in HBsAg-Positive Lymphoma Patients

Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Study

Hepatitis B e Antibody Positive before Rituximab Combination Chemotherapy Is Associated with a Lower Risk of Hepatitis B Virus (HBV) Reactivation in HBV Carriers with Diffuse Large B-Cell Lymphoma

Risk Factors of Changes in Hepatitis B Antibody Status after Allogeneic Hematopoietic Stem Cell Transplantation in Chinese Children with Thalassemia Major

Hepatitis B Related Serological Events In Hematopoietic Stem Cell Transplant Patients and Efficacy Of Lamivudine Prophylaxis Against Reactivation

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Variant RH in Patients with Sickle Cell Disease Is Associated with Clinically Significant Alloimmunization

Hepatitis B and Hepatitis C Co-Infection in Patients with Hematological Malignancies

Use of Genomics for Transfusion Therapy Management in Patients with Sickle Cell Disease

Long-Term Monitoring of Patients with Hematological Malignancies and Hepatitis B and Hepatitis C Virus Infections

Fulminant B Hepatitis in a Hepatitis B Surface Antigen-Negative Patient after Rituximab Therapy for B-CLL.

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

Dual or Single Hepatitis B and C Virus Infections in Childhood Cancer Survivors: Long-Term Follow-Up and Effect of Interferon Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only